Tri Te
Interventional Cardiology · Las Vegas, NVNPI 1447632971
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Medtronic at 29.8% of the total. Reporting peaked in 2023 at $2,544 and has fallen 65.8% since, to $871 in 2025. That places this record below the midpoint for interventional cardiology clinicians in NV, where the typical reported total is $9,708.
Across 101 payments — averaging $88.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$2K
- Penumbra, Inc.$2K
- AstraZeneca$705
- Boston Scientific$575
- Abiomed$571
- plus $826 from 12 others
What the payments were for
- Travel & lodging$3,49739%
- Food & beverage$4,50751%
- Education$88710%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 32 | $2,647 |
| Abbott | 19 | $1,930 |
| Penumbra, Inc. | 7 | $1,637 |
| AstraZeneca | 7 | $705 |
| Boston Scientific | 5 | $575 |
| Abiomed | 4 | $571 |
| Shockwave Medical, Inc | 2 | $224 |
| Cardiva Medical, Inc. | 4 | $114 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $106 |
| Medicomp Inc | 1 | $83 |
| Chiesi USA, Inc. | 1 | $72 |
| E.r. Squibb & Sons, L.L.C. | 3 | $63 |
| Philips North America LLC | 3 | $63 |
| Novartis | 2 | $38 |
| Bayer | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$1,505
- CARDIOMEMS$1,070
- ONYX FRONTIER$436
- Impella$430
- FARXIGA$368
- ENSITE PRECISION$245
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$189
- RESOLUTE ONYX$149
- BRILINTA$125
- SYMPLICITY G3$116
- GENERAL - THERAPIES$113
How this compares
$8,891 in reported general payments places this provider in the 45th percentile of 62 interventional cardiology providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 11 | $10,897 |
| ClopidogrelClopidogrel Bisulfate | 56 | $696 |
| Atorvastatin Calcium | 28 | $174 |
| Rosuvastatin Calcium | 11 | $141 |
| Metoprolol Succinate | 18 | $106 |
| Nitroglycerin | 15 | $100 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $705 | $10,89711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 62 interventional cardiology providers in Nevada.
Other interventional cardiology in Las Vegas
- Cres MirandaLas Vegas$660K
- Adrian Mercado-AlamoLas Vegas$118K
- Nayab ZafarLas Vegas$102K
- William ChuLas Vegas$75K
- Neville MistryLas Vegas$36K
- Leon VarjabedianLas Vegas$34K
- Moniz DawoodLas Vegas$29K
- Andrew LuxhojLas Vegas$22K
- Mohi AlkadriLas Vegas$20K
- John BedottoLas Vegas$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.